Efforts to Increase Representation in Prostate Cancer Clinical Trials at Lyndon B. Johnson Hospital
Recruiting · NCT07591701 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Video
What this trial is about
The main rationale underlying this study is that prostate cancer clinical trials are lacking representation from racial and ethnic minority groups. Study proposal aims to target barriers at the participant, investigator, and health system level through specific interventions to increase the percentage of participants from these backgrounds on cancer clinical trials.
Who can take part
Age range
18 Years and older
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- These criteria include diagnosed prostate cancer patients receiving care at LBJ Hospital who
- Are eligible for an open prostate cancer clinical trial at LBJ Hospital during the study period
- Can provide informed consent.
Exclusion criteria
- These criteria include prostate cancer patients receiving care at LBJ who are unable to participate due to a serious psychological or cognitive condition or have a medical condition that prevents participation in the trial.
Where it is running
1 location listed across 1 US state.
- The University of Texas M. D. Anderson Cancer Center - Houston, Texas, United States